Bechstein, Matthias http://orcid.org/0000-0002-5652-7499
Buhk, Jan-Hendrik
Frölich, Andreas Maximilian
Broocks, Gabriel
Hanning, Uta
Erler, Martin
Anđelković, Milan
Debeljak, Dragan
Fiehler, Jens
Goebell, Einar
Article History
Received: 20 August 2019
Accepted: 7 December 2019
First Online: 20 December 2019
Compliance with ethical guidelines
:
: M. Bechstein received research support from the German Research Foundation (DFG). J.-H. Buhk is consultant for Acandis, Cerenovus, Medtronic, MicroVention, Stryker and Route 92. A.M. Frölich received speaker’s fees from Penumbra Inc. J. Fiehler received research support from the German Ministry of Science and Education (BMBF), German Ministry of Economy and Innovation (BMWi), German Research Foundation (DFG), European Union (EU), Hamburgische Investitions- und Förderbank (IFB), Medtronic, Microvention, Philips, Stryker. He is consultant for Acandis, Boehringer Ingelheim, Cerenovus, Covidien, Medtronic, Microvention, Penumbra and Stryker. He holds shares in Tegus Medical. G. Broocks, U. Hanning, M. Erler, M. Andjelkovic, D. Debeljak and E. Goebell declare that they have no competing interests.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.